Medicamen Biotech Ltd

We wish to inform that the Board of Directors of the Company in its meeting held today i.e. May 29 2023 which commenced at 02.30 p.m. and concluded at 04.00 p.m. inter alia considered and approved the Audited Standalone & Consolidated Financial Results of the Company for year ended March 31 2023 further details attached.